BioSpace News Archive

Baudax Bio, Inc. (“Baudax” or the “Company”) (Nasdaq: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced the closing of the previously announced public offering, reflective of 7,692,308 shares of its common stock

Infusion therapy involves use of needle or catheter during treatment. This is prescribed to only when patients condition is very serious, that they are not responding to oral medication.

CardioQuipTM, LLC, a medical device manufacturer focused on development and commercialization of patient temperature control and cardiovascular perfusion technology announced today it has received CE Mark approval for the MCH-1000TM Modular Cooler-Heater SeriesTM.

The management team will host a conference call today, Thursday, March 26th in English at 2:30 pm EDT (New York time) / 7:30 pm CET (Paris time). A presentation will be available in the Investors section of the Poxel website.

Tabula Rasa HealthCare®, Inc. (“TRHC”) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, has named Frank Sparacino Senior Vice President of Investor Relations and Corporate Development.

Advarra announces the availability of free resources to support and enable the clinical research community and ongoing research during the coronavirus disease (COVID-19) crisis.

Tetra Bio-Pharma Inc . (“ Tetra ” or the “ Company ”) (TSX-V:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, today announced the results of a survey conducted among US and Canadian patients and physicians which validated the primary endpoint of the SERENITY © pivotal trial. The results confirm that the primary endpoint in the SERENITY © clinical trial is accurate About Cancer Cachexia Fifty to 80% of cancer

Prevail Therapeutics today reported financial results for the full year ended December 31, 2019, and reviewed recent business highlights.

IntelGenx Technologies Corp. reported financial results for the fourth quarter and twelve-month periods ended December 31, 2019.

The world’s first whole-body portable ultrasound continues its rapid expansion and distribution around the world while also showing significant clinical utility in fighting the COVID-19 pandemic [26-March-2020] GUILFORD, Conn. , March 26, 2020 /PRNewswire/ -- Butterfly Network, the company helping to transform healthcare with its disruptive, ultrasound-on-chip™ techno